Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
23
FSPKF Quote, Financials, Valuation and Earnings
Last price:
$19.26
Seasonality move
:
3.76%
Day range:
$19.26 - $19.26
52-week range:
$16.35 - $25.91
Dividend yield:
1.81%
P/E ratio:
44.45x
P/S ratio:
8.91x
P/B ratio:
100.48x
Volume:
--
Avg. volume:
112
1-year change:
-25.67%
Market cap:
$11.3B
Revenue:
$1.2B
EPS (TTM):
$0.43
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Fisher & Paykel Healthcare Corp. Ltd. has -- downside to fair value with a price target of -- per share.
FSPKF vs. S&P 500
-
Over the past 5 trading days, Fisher & Paykel Healthcare Corp. Ltd. has underperformed the S&P 500 by -17.9% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Fisher & Paykel Healthcare Corp. Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Fisher & Paykel Healthcare Corp. Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Fisher & Paykel Healthcare Corp. Ltd. reported revenues of $723.8M.
Earnings Growth
-
Fisher & Paykel Healthcare Corp. Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Fisher & Paykel Healthcare Corp. Ltd. reported earnings per share of $0.36.
Enterprise value:
11.1B
EV / Invested capital:
--
Price / LTM sales:
8.91x
EV / EBIT:
31.71x
EV / Revenue:
8.71x
PEG ratio (5yr expected):
0.78x
EV / Free cash flow:
42.97x
Price / Operating cash flow:
43.91x
Enterprise value / EBITDA:
25.45x
Gross Profit (TTM):
$814.7M
Return On Assets:
15.15%
Net Income Margin (TTM):
20.04%
Return On Equity:
19.71%
Return On Invested Capital:
18.6%
Operating Margin:
-28.98%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $988M | $1.1B | $1.2B | -- | $723.8M | |
| Gross Profit | $588.3M | $645.7M | $754.5M | -- | $299.7M | |
| Operating Income | $211M | $224.6M | $302.8M | -- | -$209.7M | |
| EBITDA | $272.7M | $294.3M | $385.8M | -- | $369.9M | |
| Diluted EPS | $0.27 | $0.14 | $0.38 | -- | $0.36 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $596.2M | $415.5M | $436.9M | $487.3M | -- | |
| Total Assets | $1.4B | $1.2B | $1.4B | $1.5B | -- | |
| Current Liabilities | $215.9M | $211.6M | $171.9M | $236.6M | -- | |
| Total Liabilities | $312.3M | $353.7M | $382.3M | $320.9M | -- | |
| Total Equity | $1.1B | $848.7M | $1B | $1.2B | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2015-04-30 | 2016-04-30 | 2017-04-30 | 2016-04-30 | 2017-04-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $120.9M | $135.7M | |
| Cash From Investing | -- | -- | -- | $108.7M | $110.3M | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
FSPKF
Sector
Market Cap
$11.3B
$28.4M
Price % of 52-Week High
74.33%
51.17%
Dividend Yield
1.81%
0%
Shareholder Yield
1.87%
-1.49%
1-Year Price Total Return
-25.67%
-16.67%
Beta (5-Year)
1.201
0.518
Dividend yield:
1.81%
Annualized payout:
$0.40
Payout ratio:
52.1%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$20.57
200-day SMA
Sell
Level
$20.07
Bollinger Bands (100)
Sell
Level
19.8 - 21.62
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$21.17
Relative Strength Index (RSI14)
Sell
Level
29.41
ADX Line
Sell
Level
51.66
Williams %R
Buy
Level
-93.7343
50-day SMA
Sell
Level
$21.11
MACD (12, 26)
Sell
Level
-0.42
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Sell
Level
-4
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (18.2552)
Buy
CA Score
(Annual)
Level (2.0196)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-3.7266)
Buy
Piotroski F Score
(Annual)
Level (9)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.
Stock Forecast FAQ
In the current month, FSPKF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The FSPKF average analyst price target in the past 3 months is --.
-
Where Will Fisher & Paykel Healthcare Corp. Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Fisher & Paykel Healthcare Corp. Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Fisher & Paykel Healthcare Corp. Ltd.?
Analysts are divided on their view about Fisher & Paykel Healthcare Corp. Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Fisher & Paykel Healthcare Corp. Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is Fisher & Paykel Healthcare Corp. Ltd.'s Price Target?
The price target for Fisher & Paykel Healthcare Corp. Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is FSPKF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Fisher & Paykel Healthcare Corp. Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of FSPKF?
You can purchase shares of Fisher & Paykel Healthcare Corp. Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Fisher & Paykel Healthcare Corp. Ltd. shares.
-
What Is The Fisher & Paykel Healthcare Corp. Ltd. Share Price Today?
Fisher & Paykel Healthcare Corp. Ltd. was last trading at $19.26 per share. This represents the most recent stock quote for Fisher & Paykel Healthcare Corp. Ltd.. Yesterday, Fisher & Paykel Healthcare Corp. Ltd. closed at $19.26 per share.
-
How To Buy Fisher & Paykel Healthcare Corp. Ltd. Stock Online?
In order to purchase Fisher & Paykel Healthcare Corp. Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get FSPKF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FSPKF
Sector
P/E ratio
44.45x
23.89x
PEG ratio
0.78x
-0.01x
P/B ratio
100.48x
1.81x
Price / LTM sales
8.91x
1.58x
Growth Metrics
FSPKF
Sector
Revenue growth
--
4.62%
Earnings growth
--
10.7%
Revenue (5-year growth)
7.83%
6.5%
Earnings forecast
--
-$0.21
Profitability
FSPKF
Sector
Profitability FY 2024
$755.9M
$3.6M
Return on invested capital
18.6%
-31.84%
Return on assets
15.15%
-27.96%
Return on equity
19.71%
-37.63%
Earnings Date
Last Earnings Date
Nov
26
Next Earnings Date
May
28
Estimated Next Earnings Date
Feb
25
Balance Sheet
FSPKF
Sector
Total cash
$150.9M
$26.4M
Short term investments
--
$25.7M
Total assets
$1.4B
$76.9M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 23
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
